.In the middle of the hereditary medications arms race, Main Pioneering is introducing a brand new business to help biotechs tweak the accuracy of their
Read moreFierce Biotech’s Gabrielle Masson offers Intense 15 at NYSE
.Fierce Biotech Partner Editor Gabrielle Masson offered the 2024 class of Fierce 15 champions on the floor of the New York Stock Exchange on Wednesday.Masson
Read moreFierce Biotech Editor-in-Chief Ayla Ellison Talks Patronize Michelle Benz on the Future of Biotech.
.Allow’s dive into a discussion along with Ayla Ellison, Fierce Biotech Managing Editor and Michelle Benz as they cover the highlights and also pleasure surrounding
Read moreFibroGen gives up 75% of US workers as possession flunks 2 additional tests
.FibroGen is radically reorganizing its own company, laying off 75% of its own USA team and stopping financial investment in its own lead applicant in
Read moreF 2G raises $100M for 2nd try to receive new antifungal to market
.After F2G’s very first attempt to acquire a brand-new training class of antifungal to market was hindered due to the FDA, the U.K.-based biotech has
Read moreFDA worried Iterum’s urinary system system infection drug could possibly lead to antimicrobial resistance
.Five months after endorsing Utility Therapies’ Pivya as the first brand new therapy for simple urinary system tract infections (uUTIs) in greater than two decades,
Read moreFDA puts partial hold on BioNTech-OncoC4 stage 3 test
.The FDA has executed a partial hang on a phase 3 non-small tissue lung cancer cells trial run by BioNTech and OncoC4 after observing differing
Read moreFDA places Kezar lupus test in hold adhering to 4 individual deaths
.The FDA has put Kezar Lifestyle Sciences’ lupus trial on hold after the biotech flagged four fatalities in the course of the stage 2b study.Kezar
Read moreFDA fragments adcomm for Applied’s rare disease medicine
.After dismissing the selection meeting for Applied Therapeutics’ metabolic disorder medication govorestat, the FDA has actually now chosen that a planned advisory board meeting will
Read moreFDA broadens probing right into Lykos’ MDMA trials: WSJ
.For Lykos Therapeutics as well as the firm’s potential MDMA-assisted therapy for trauma (PTSD), the hits merely maintain happening..Previously this month, Lykos was struck by
Read more